Get my own profile
Public access
View all9 articles
0 articles
available
not available
Based on funding mandates
Co-authors
David BarbieDana-Farber Cancer InstituteVerified email at partners.org
Nurit HaspelAssociate Professor of Computer Science, University of Massachusetts BostonVerified email at umb.edu
Michael TolstorukovDana-Farber Cancer InstituteVerified email at mail.dfci.harvard.edu
Erik KnelsonMerckVerified email at merck.com
Mark M. AwadChief, Thoracic Oncology, Memorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Andrey LobodaDirector, Computational and Systems Biology, MerckVerified email at merck.com
Kourosh ZarringhalamDepartment of Mathematics UMass BostonVerified email at umb.edu
Matthew OserDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
Pasi JanneDana Farber Cancer InstituteVerified email at dfci.harvard.edu
Razvan CristescuDistinguished Scientist, MerckVerified email at merck.com
Biagio RicciutiLowe Center for Thoracic Oncology, Dana-Farber Cancer InstituteVerified email at dfci.harvard.edu
Tosha ShahMerckVerified email at merck.com
Antong ChenExecutive Director, Data Science and Scientific Informatics, Merck & Co., Inc.Verified email at merck.com
Kin-Hoe ChowSigilon Therapeutics, a wholly subsidiary of Eli Lilly and Company